J. Hans DeVries

25.4k total citations · 8 hit papers
235 papers, 13.1k citations indexed

About

J. Hans DeVries is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, J. Hans DeVries has authored 235 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Endocrinology, Diabetes and Metabolism, 86 papers in Surgery and 57 papers in Genetics. Recurrent topics in J. Hans DeVries's work include Diabetes Management and Research (150 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (85 papers) and Diabetes Treatment and Management (67 papers). J. Hans DeVries is often cited by papers focused on Diabetes Management and Research (150 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (85 papers) and Diabetes Treatment and Management (67 papers). J. Hans DeVries collaborates with scholars based in Netherlands, United States and Germany. J. Hans DeVries's co-authors include J. B. L. Hoekstra, Jeroen Hermanides, F. Holleman, Titia M. Vriesendorp, Sarah E. Siegelaar, Frank J. Snoek, Frank D. Verbraak, I. M. E. Wentholt, Reinier O. Schlingemann and Pauline H. B. Kok and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

J. Hans DeVries

229 papers receiving 12.6k citations

Hit Papers

Practical recommendations for the management of diab... 2016 2026 2019 2022 2020 2016 2021 2017 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Practical recommendations for the management of diabetes in patients with COVID-19
    2020 611 citations J. Hans DeVries, Éric Renard et al. profile →
  2. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus
    2016 492 citations J. Hans DeVries et al. profile →
  3. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2021 349 citations J. Hans DeVries, Kirsten Nørgaard et al. Diabetes Care profile →
  4. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
    2017 340 citations J. Hans DeVries et al. profile →
  5. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
    2016 289 citations C.A.J. van Beers, J. Hans DeVries et al. profile →
  6. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2021 225 citations J. Hans DeVries, Kirsten Nørgaard et al. profile →
  7. Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
    2023 120 citations Tim Heise, J. Hans DeVries et al. Diabetes Care profile →
  8. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
    2024 60 citations Frank L.J. Visseren, Arianne C. van Bon et al. profile →

Peers

J. Hans DeVries
David R. Owens United Kingdom
Graham Leese United Kingdom
Bruce A. Perkins Canada
David M. Nathan United States
Peter G. Colman Australia
Mohammed Saad United States
Angelo Avogaro Italy
Andrzej S. Królewski United States
Mark E. Molitch United States
Janet B. McGill United States
David R. Owens United Kingdom
J. Hans DeVries
Citations per year, relative to J. Hans DeVries J. Hans DeVries (= 1×) peers David R. Owens

Countries citing papers authored by J. Hans DeVries

Since Specialization
Citations

This map shows the geographic impact of J. Hans DeVries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Hans DeVries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Hans DeVries more than expected).

Fields of papers citing papers by J. Hans DeVries

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Hans DeVries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Hans DeVries. The network helps show where J. Hans DeVries may publish in the future.

Co-authorship network of co-authors of J. Hans DeVries

This figure shows the co-authorship network connecting the top 25 collaborators of J. Hans DeVries. A scholar is included among the top collaborators of J. Hans DeVries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Hans DeVries. J. Hans DeVries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eliasson, Björn, Hertzel C. Gerstein, Katarina Eeg‐Olofsson, et al.. (2025). Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study. Diabetes Care. 48(11). 1888–1895.
2.
Mather, Kieren J., Andrea Mari, Govinda J. Weerakkody, et al.. (2025). Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis. Diabetes Obesity and Metabolism. 27(3). 1507–1514. 7 indexed citations
3.
Mather, Kieren J., Andrea Mari, Tim Heise, et al.. (2024). Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test. The Journal of Clinical Endocrinology & Metabolism. 109(12). 3046–3054. 12 indexed citations
4.
Franx, Arie, et al.. (2024). The WHO 2013 oral glucose tolerance test: The utility of isolated glucose measurements - A retrospective cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 296. 371–375. 1 indexed citations
5.
DeVries, J. Hans, Arie Franx, Bas B. van Rijn, et al.. (2023). Fetal and post‐natal outcomes in offspring after intrauterine metformin exposure: A systematic review and meta‐analysis of animal experiments. Diabetic Medicine. 41(2). e15243–e15243. 2 indexed citations
6.
Willems, Hanna C., Gert J. Geurtsen, Abraham H. Hulst, et al.. (2022). Comparison of Postoperative Neurocognitive Function in Older Adult Patients with and without Diabetes Mellitus. Gerontology. 69(2). 189–200. 5 indexed citations
7.
8.
Klonoff, David C., Mark L. Evans, Wendy Lane, et al.. (2018). A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5). Diabetes Obesity and Metabolism. 21(4). 961–967. 57 indexed citations
9.
Hulst, Abraham H., Marc B. Godfried, Thierry V. Scohy, et al.. (2018). Study protocol of the randomised placebo-controlled GLOBE trial: GL P-1 f o r b ridging of hyperglyca e mia during cardiac surgery. BMJ Open. 8(6). e022189–e022189. 9 indexed citations
10.
Beers, C.A.J. van, Maartje de Wit, Petronella Geelhoed-Duijvestijn, et al.. (2017). Continuous Glucose Monitoring in Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycemia: Also Effective in Patients with Psychological Distress?. Diabetes Technology & Therapeutics. 19(10). 595–599. 11 indexed citations
11.
Messori, Mirko, Jort Kropff, Simone Del Favero, et al.. (2017). Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions. Diabetes Technology & Therapeutics. 19(10). 560–571. 43 indexed citations
12.
Keith-Hynes, Patrick, et al.. (2016). A Review of Safety and Design Requirements of the Artificial Pancreas. Annals of Biomedical Engineering. 44(11). 3158–3172. 42 indexed citations
13.
Dijk, Peter R. van, Klaas H. Groenier, J. Hans DeVries, et al.. (2015). Continuous Intraperitoneal Insulin Infusion Versus Subcutaneous Insulin Therapy in the Treatment of Type 1 Diabetes: Effects on Glycemic Variability. Diabetes Technology & Therapeutics. 17(6). 379–384. 13 indexed citations
14.
Bon, Arianne C. van, et al.. (2013). Feasibility of a Portable Bihormonal Closed-Loop System to Control Glucose Excursions at Home Under Free-Living Conditions for 48 Hours. Diabetes Technology & Therapeutics. 16(3). 131–136. 61 indexed citations
15.
Sechterberger, Marjolein K., Yoeri M. Luijf, & J. Hans DeVries. (2013). Poor Agreement of Computerized Calculators for Mean Amplitude of Glycemic Excursions. Diabetes Technology & Therapeutics. 16(2). 72–75. 16 indexed citations
16.
Qu, Yongming, et al.. (2012). Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data. Diabetes Technology & Therapeutics. 14(11). 1008–1012. 98 indexed citations
17.
18.
Bon, Arianne C. van, et al.. (2011). Future Acceptance of an Artificial Pancreas in Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 13(7). 731–736. 35 indexed citations
19.
Hermanides, Jeroen, Kirsten Nørgaard, Daniela Bruttomesso, et al.. (2009). Sensor augmented pump therapy substantially lowers HbA(1c); a randomized controlled trial. Lund University Publications (Lund University). 6 indexed citations
20.
Swinnen, S. G. H. A., Frank J. Snoek, Marie‐Paule Dain, et al.. (2009). Rationale, Design, and Baseline Data of the Insulin Glargine (Lantus) Versus Insulin Detemir (Levemir) Treat-To-Target (L2T3) Study: A Multinational, Randomized Noninferiority Trial of Basal Insulin Initiation in Type 2 Diabetes. Diabetes Technology & Therapeutics. 11(11). 739–743. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David R. Owens Breakdown of academic impact, for papers by Graham Leese Breakdown of academic impact, for papers by Bruce A. Perkins Breakdown of academic impact, for papers by David M. Nathan Breakdown of academic impact, for papers by Peter G. Colman Breakdown of academic impact, for papers by Mohammed Saad Breakdown of academic impact, for papers by Angelo Avogaro Breakdown of academic impact, for papers by Andrzej S. Królewski Breakdown of academic impact, for papers by Mark E. Molitch Breakdown of academic impact, for papers by Janet B. McGill
Rankless by CCL
2026